The Role of Heme Oxygenase-1 in Remote Ischemic and Anesthetic Organ Conditioning
The cytoprotective effects of the heme oxygenase (HO) pathway are widely acknowledged. These effects are mainly mediated by degradation of free, pro-oxidant heme and the generation of carbon monoxide (CO) and biliverdin. The underlying mechanisms of protection include anti-oxidant, anti-apoptotic, a...
Saved in:
Main Authors: | , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2019-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_c67a6f6b5e0d4620b13b67774b38d9c9 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Inge Bauer |e author |
700 | 1 | 0 | |a Annika Raupach |e author |
245 | 0 | 0 | |a The Role of Heme Oxygenase-1 in Remote Ischemic and Anesthetic Organ Conditioning |
260 | |b MDPI AG, |c 2019-09-01T00:00:00Z. | ||
500 | |a 2076-3921 | ||
500 | |a 10.3390/antiox8090403 | ||
520 | |a The cytoprotective effects of the heme oxygenase (HO) pathway are widely acknowledged. These effects are mainly mediated by degradation of free, pro-oxidant heme and the generation of carbon monoxide (CO) and biliverdin. The underlying mechanisms of protection include anti-oxidant, anti-apoptotic, anti-inflammatory and vasodilatory properties. Upregulation of the inducible isoform HO-1 under stress conditions plays a crucial role in preventing or reducing cell damage. Therefore, modulation of the HO-1 system might provide an efficient strategy for organ protection. Pharmacological agents investigated in the context of organ conditioning include clinically used anesthetics and sedatives. A review from Hoetzel and Schmidt from 2010 nicely summarized the effects of anesthetics on HO-1 expression and their role in disease models. They concluded that HO-1 upregulation by anesthetics might prevent or at least reduce organ injury due to harmful stimuli. Due to its clinical safety, anesthetic conditioning might represent an attractive pharmacological tool for HO-1 modulation in patients. Remote ischemic conditioning (RIC), first described in 1993, represents a similar secure option to induce organ protection, especially in its non-invasive form. The efficacy of RIC has been intensively studied herein, including on patients. Studies on the role of RIC in influencing HO-1 expression to induce organ protection are emerging. In the first part of this review, recently published pre-clinical and clinical studies investigating the effects of anesthetics on HO-1 expression patterns, the underlying signaling pathways mediating modulation and its causative role in organ protection are summarized. The second part of this review sums up the effects of RIC. | ||
546 | |a EN | ||
690 | |a heme oxygenase-1 | ||
690 | |a remote ischemic conditioning | ||
690 | |a anesthetic conditioning | ||
690 | |a organ protection | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Antioxidants, Vol 8, Iss 9, p 403 (2019) | |
787 | 0 | |n https://www.mdpi.com/2076-3921/8/9/403 | |
787 | 0 | |n https://doaj.org/toc/2076-3921 | |
856 | 4 | 1 | |u https://doaj.org/article/c67a6f6b5e0d4620b13b67774b38d9c9 |z Connect to this object online. |